Photo by rawpixel.com on Pexels.com

Investor Testing of the Proposed Relationship Summary for Investment Advisers and Broker-Dealers

Investor Testing of the Proposed Relationship Summary for Investment Advisers and Broker-Dealers

FOR IMMEDIATE RELEASE
2018-257

Washington D.C., Nov. 7, 2018 —
In connection with our ongoing efforts to help address investor confusion about the nature of their relationships with investment advisers and broker-dealers, the SEC’s Office of the Investor Advocate today made available a report on investor testing conducted by the RAND Corporation. The investor testing gathered feedback on a sample Relationship Summary issued in April 2018 as part of a package of proposed rule-makings and interpretations designed to enhance the quality and transparency of investors’ relationships with investment advisers and broker-dealers. The report is available for review and comment on the SEC’s website.

“Based on my discussions with many retail investors over the last several months, it is clear to me that too many retail investors are not aware of the material aspects of their relationships with their investment professionals,” said SEC Chairman Jay Clayton. “The results of RAND Corporation’s investor testing support our efforts to provide retail investors with a clear and concise Relationship Summary to help them make important decisions about choosing to work with an investment professional. The SEC staff is carefully reviewing RAND Corporation’s investor testing report as well as other information related to the proposed Relationship Summary that is available in the comment file.”

RAND Corporation’s investor testing of the Relationship Summary consisted of:

A nationwide online survey of over 1,800 individuals fielded through RAND’s nationally representative American Life Panel
Qualitative in-depth interviews conducted in Denver and Pittsburgh fielded using independent market research firms
This report may be informative to those evaluating the proposed Relationship Summary. This report may supplement other information considered in connection with the final rule, and the Office of Investor Advocate is making this report available to allow the public to consider and comment on this supplemental information. Comments on this supplemental information may be submitted to comment File Nos. S7-08-18, S7-09-18, and S7-07-18 and are encouraged by Dec. 7, 2018.

###

Source:

SEC.gov | Investor Testing of the Proposed Relationship Summary for Investment Advisers and Broker-Dealers

“Based on my discussions with many retail investors over the last several months, it is clear to me that too many retail investors are not aware of the material aspects of their relationships with their investment professionals,” said SEC Chairman Jay Clayton.

Glenford Robinson

I am a Clinical Lab Scientist, entrepreneur, investor and trader (stocks and Forex). I enjoy writing and publishing articles online.

Check Also

Two ICO Issuers Settle SEC Registration Charges, Agree to Register Tokens as Securities

SEC Imposed civil penalties on ICO security issuers who did not register their ICO offerings with the SEC...

Crocs, Inc., Stock (CROX) Jumped 26.66% to $27.80 Per Share on Thursday After the Company Reported Third Quarter Revenue of $261 Million

Crocs, Inc., Reported Earning Increase of $261 million; Comapany's stock CROX leaped 26.66%.

Twilio Stock (TWLO) Climed Sharply Today, Up 35.34% After the Company Reported Better than Expected Third Quarter Earnings of $168.9 Million

Twilio stock price rose sharply today after year over year 3Q earnings of 168.9 Million...

Sports Medicine Market Leader Vericel Stock (VCEL) Skyrockets After Reporting Record Revenue of $22.5 Million

Sports Medicine Market Leader Vericel Reported Record Revenued in the Millions; Stock Went Hyperbolic: Trading Higher This Morning

Datawatch Corp Stock (DWCH) Top Gainer On Monday, Why? Here is Why…

Datawatch Corporations Stock (NASDAQ: DWCH )Top Gainer Today Nov. 5, 2018 as a Result of Buyout By Altair (NASDAQ: ALTR)

SEC Adopts Rules That Increase Information Brokers Must Provide to Investors on Order Handling

SEC Adopts Amendments to Regulation for Broker-Dealer Handling of Customer Orders

FDA Warns Patients and Doctors About Risk of Inaccurate Results From Home-Use Device to Monitor Blood Thinner Warfarin

FDA Warns that the Warfarin Test Kit CoaguChek XS PT Test Strips may provide results higher than the actual INR.

%d bloggers like this: